Skip to main content
. 2015 Jul 22;12(9):3214–3225. doi: 10.1021/acs.molpharmaceut.5b00168

Table 4. Effect of Cerebral Blood Flow on Brain-to-Blood (Kb,brain) and Brain-to-Plasma (Kp,brain) Concentration Ratios Determined at 25 min after Injection of (R)-[11C]Verapamil and [11C]-N-Desmethyl-loperamide in Wild-Type FVB/N and Abcb1a/1b(−/−) Micea.

  isoflurane
awake
  wild-type Abcb1a/1b(−/−) fold increase wild-type Abcb1a/1b(−/−) fold increase
(R)-[11C]Verapamil
n 4 4   4 4  
Kb,brain 0.49 ± 0.11 2.60 ± 0.37 5.3 0.53 ± 0.04 2.77 ± 0.26 5.2
Kp,brain 0.35 ± 0.09 1.91 ± 0.21 5.4 0.38 ± 0.03 2.15 ± 0.18 5.7
[11C]-N-Desmethyl-loperamide
n 3 4   5 6  
Kb,brain 0.25 ± 0.06 1.42 ± 0.4 5.7 0.21 ± 0.05 2.84 ± 0.14b 13.8
Kp,brain 0.20 ± 0.04 1.21 ± 0.41 6.0 0.20 ± 0.05 2.79 ± 0.20b 13.7
N-Isopropyl-p-[125I]iodo-amphetamine
n 4     4    
Kb,brain 12.2 ± 0.4 nd nd 7.5 ± 0.8b nd nd
a

Relative cerebral blood flow was assessed by measurement of Kb,brain of N-isopropyl-p-[125I]iodoamphetamine at 5 min after iv injection under otherwise identical experimental conditions. All data are given as mean ± SD; nd = not determined.

b

P < 0.001 when compared to corresponding isoflurane group (2-tailed t-test).